BridgeMD
New treatment option for High Resolution Vessel Wall Imaging
Official title Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs
ClinicalTrials.gov ID: NCT06754956
What this study is testing
- What it's testing
- Atherosclerotic stenosis of the carotid and intracranial arteries is one of the leading causes of ischemic cerebrovascular events worldwide. Among these, intracranial atherosclerotic stenosis has an incidence rate of up to 46.6% in patients with ischemic stroke or transient ischemic attack (TIA) in China.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 95
You may be able to join if
- Age ≥ 18 years;
- Moderate to severe intracranial or extracranial arterial stenosis (stenosis degree: 50% to 99%, confirmed by CTA, MRA, or DSA);
- Written informed consent signed by the patient or their legal representative.
You likely can't join if
- Non-atherosclerotic intracranial arterial stenosis, such as dissection or moyamoya disease;
- Contraindications to MRI, such as claustrophobia or presence of a cardiac pacemaker;
- Allergy to gadolinium-based contrast agents;
- Poor MRI image quality preventing analysis;
- Abnormal liver or kidney function;
- History of any prior endovascular treatment;
See the full eligibility criteria
- Age ≥ 18 years;
- Moderate to severe intracranial or extracranial arterial stenosis (stenosis degree: 50% to 99%, confirmed by CTA, MRA, or DSA);
- Written informed consent signed by the patient or their legal representative.
- Non-atherosclerotic intracranial arterial stenosis, such as dissection or moyamoya disease;
- Contraindications to MRI, such as claustrophobia or presence of a cardiac pacemaker;
- Allergy to gadolinium-based contrast agents;
- Poor MRI image quality preventing analysis;
- Abnormal liver or kidney function;
- History of any prior endovascular treatment;
- Presence of implants posing potential safety risks in 5.0T MRI, such as non-removable metallic dental prostheses, stents, or other metallic implants.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 95 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.